Nightingale Health attains UKCA marking for its blood analysis technology to bring its technology to healthcare use in the United Kingdom
Nightingale Health Plc Press release 20 August 2024 at 9:45 a.m. (EEST) Nightingale Health Plc (“Nightingale Health”), a pioneer in disease risk detection and preventative health, has attained UKCA (UK Conformity Assessed) marking under the UK Medical Devices Regulations. Nightingale Health has already been working for years with many leading universities in the UK and the technology is being used by many landmark health initiatives, such as the UK Biobank, to profile their entire sample collections. To expand its activities in the UK, Nightingale Health has established